🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)

RecruitingNAAges 18 Years - anyAllThe University of Queensland
NCT04932148 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The INCH-HD trial will test if incremental HD preserves the quality of life of patients and families and is a safe, practical, cost effective treatment option.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adults (≥ 18 years of age) and 2. Commencing HD as their initial dialysis therapy and 3. Able to give informed consent Exclusion Criteria: 1. Urine output \<0.5Litres/day 2. Unlikely to be on HD for ≥1 year.
💊

What it tests

  • Incremental HD
  • Conventional HD
📍

Where

18 sites
Concord Repatriation General Hospital
Concord, Australia
Northern Beaches Hospital
Frenchs Forest, Australia
St George Hospital
Kogarah, Australia
Liverpool Hospital
Liverpool, Australia
John Hunter Hospital
New Lambton Heights, Australia
Port Macquarie Hospital
Port Macquarie, Australia
Royal North Shore Hospital
Saint Leonards, Australia
Bundaberg Hospital
Bundaberg, Australia

…and 10 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy